Foundation Medicine Announces Key Developments in International Commercialization Efforts
Posted: Monday, May 12, 2014
News
ASCO, ESMO, EORTC, ESO and UICC Continue Endorsing the WIN Symposium Series in 2014
Posted: Wednesday, April 16, 2014
WIN Consortium Appoints Winston and Strawn LLP as Official Legal Counsel
Posted: Wednesday, February 26, 2014
AstraZeneca, DKFZ and EORTC Join WIN Consortium
Posted: Friday, January 24, 2014
Scott P. Serota, BCBSA President and CEO, to deliver opening address at WIN 2014 Symposium
Posted: Wednesday, January 22, 2014
Top experts in tumor biology and precision cancer medicine to present at WIN 2014 Symposium
Posted: Tuesday, September 24, 2013
WIN2014 Symposium June 23-24: “WINning Combinations for Precision Cancer Medicine”
Posted: Thursday, September 12, 2013
WIN Consortium Receives 3 Million Euro EU FP7 Grant to Conduct WINTHER
Posted: Tuesday, September 03, 2013
Promises and challenges of personalized cancer medicine addressed at WIN Symposium 2013
Posted: Wednesday, July 24, 2013
CANCER MEDECINE PERSONNALISEE CONGRES RECHERCHE BIOMEDICALE CLCC DIAGNOSTIC
Posted: Friday, July 12, 2013
WIN Symposium Endorsed by American Society of Clinical Oncology (ASCO®) for 5th Consecutive Year
Posted: Tuesday, June 25, 2013
WIN Consortium Welcomes the Blue Cross and Blue Shield Association as its first Health Plan Member
Posted: Tuesday, June 18, 2013